GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Global Health Ltd

Global Health Q2 FY27 Standalone Profit After Tax up to INR 1,812.59 million

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 03 Nov 2026, 04:03 PM IST  ·  BSE ID: 5a304fd4-c70b-4514-8149-0d410512b08a
View Original BSE Filing (PDF)
💡
In Simple Terms
Global Health's financial results show a jump in Q2 FY27 profit, and the company approved funds for a new 500-bed hospital.
🤖 AI Summary
  • Board approved unaudited Standalone and Consolidated Financial Results for Q2 FY27 and Half Year ended September 30, 2026.
  • Standalone Profit After Tax for Q2 FY27 was INR 1,812.59 million, an increase from INR 1,401.99 million in Q2 FY26.
  • Standalone Revenue from Operations for Q2 FY27 reached INR 12,080.94 million, up from INR 9,264.28 million in Q2 FY26.
  • Project budget of Rs. 997 Crores approved for a new 500-bedded hospital at Ghaziabad, Uttar Pradesh.
  • Statutory Auditors, M/s Walker Chandiok & Co LLP, issued unmodified opinions on the financial results.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Standalone Revenue from operations (Q2 FY27)
INR 12,080.94 million
30.41%
Standalone Profit After Tax (Q2 FY27)
INR 1,812.59 million
29.29%
Standalone Total Expenses (Q2 FY27)
INR 9,909.07 million
27.01%
New Hospital Project Budget
Rs. 997 Crores
🏢 How This Affects the Company
📈
Business Impact
The approval of Rs. 997 Crores for a new 500-bedded hospital in Ghaziabad indicates a strategic expansion, adding significant capacity to the company's healthcare network. This expansion could enhance regional market presence.
💰
Financial Impact
The standalone Profit After Tax for Q2 FY27 increased to INR 1,812.59 million, demonstrating improved profitability compared to the prior year. The capital expenditure for the new hospital will impact future cash flows and asset base.
⚙️
Operational Impact
The planned 500-bedded hospital will increase Global Health's operational capacity, requiring new staff and management. Construction and operationalization of this facility will be a key operational focus.
⚠️
Risk Impact
The significant capital outlay of Rs. 997 Crores for the new hospital introduces execution risk related to construction timelines, regulatory approvals, and market absorption. However, it also diversifies geographical presence.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with Q2 FY27 standalone Basic Earnings per Share at INR 6.75, compared to INR 5.22 in Q2 FY26. The new hospital project may affect future growth and capital allocation.
🔍
Management Signal
Management's decision to approve a Rs. 997 Crores project budget for a new 500-bedded hospital signals a clear intent for expansion and increased operational capacity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check revenue and profit growth trends.
Updates on Ghaziabad hospital construction — monitor progress and timelines.
Press releases regarding the new hospital — look for operational details and bed capacity.
MEDIUM RISK New large-scale hospital project introduces execution risks and capital expenditure commitments.
💡 Investor Takeaway
Global Health reported Q2 FY27 standalone Revenue from Operations at INR 12,080.94 million, up 30.41% year-on-year. Standalone Profit After Tax rose 29.29% to INR 1,812.59 million. The Board also approved Rs. 997 Crores for a new 500-bedded Ghaziabad hospital.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Profit After Tax for Q2 FY27 increased by 29.29% to INR 1,812.59 million from INR 1,401.99 million in Q2 FY26.
  • Standalone Revenue from Operations for Q2 FY27 grew by 30.41% to INR 12,080.94 million from INR 9,264.28 million in Q2 FY26.
📅 Company Track Record
Global Health Limited has consistently reported growth, with Q1 FY27 Total Income growing 26.2% to INR 13,262 million. Q2 FY27 revenue is up 33.6% to INR 14,690 million (consolidated, from past filing context), and Q2 FY27 standalone PAT up 29.29% to INR 1,812.59 million, indicating a pattern of strong financial performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Global Health's standalone Profit After Tax for Q2 FY27?
Global Health's standalone Profit After Tax for the quarter ended September 30, 2026 (Q2 FY27) was INR 1,812.59 million, which is a 29.29% increase from INR 1,401.99 million in Q2 FY26.
What was Global Health's standalone Revenue from Operations for Q2 FY27?
Global Health reported standalone Revenue from Operations of INR 12,080.94 million for Q2 FY27, showing a 30.41% increase compared to INR 9,264.28 million in Q2 FY26.
What new project did Global Health's Board approve?
Global Health's Board approved a project budget of Rs. 997 Crores for the construction of a new 500-bedded hospital at Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh.
What were Global Health's standalone Basic Earnings per Share for Q2 FY27?
Global Health's standalone Basic Earnings per Share for Q2 FY27 was INR 6.75, compared to INR 5.22 for the quarter ended September 30, 2025 (Q2 FY26).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.